Bird Flu Vaccine ‘Encouraging’
An Australian drug company trying to develop a vaccine against bird flu said on Friday that early results from clinical trials were encouraging.
CSL Ltd, based in the southern city of Melbourne, said it was confident the prototype for an H5N1 vaccine was safe and effective.
CSL began testing the vaccine on 400 human volunteers in October. It now plans to extend the trial to determine optimal doses and to test a broader range of age groups including infants and the elderly.
You may also like to read
- Bird Flu Vaccine for Humans is Not Difficult, Says, Leading Vaccine Producer
- Bird Flu Vaccine : Latest Review
- Oral Bird Flu Vaccine from Russia
- UK 'Developing Bird Flu Vaccine'
- Ten Years to Develop an Effective Bird Flu Vaccine
- What is the Status of a Vaccine Against Bird Flu for Humans?
- New bird flu vaccine could be used to protect multiple animal species: assured USA scientists
- China Would Soon Being Testing Bird Flu Vaccine
- Bird Flu Vaccine Could Be Industrially Produced By February
- Unauthorized Bird Flu Vaccine Trial Killed 21 Homeless People
